Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer

By Lidgren Mathias   Wilking Nils   Jonsson Bengt   Rehnberg Clas  

Acta Oncologica, Vol. 47, Iss. 6, 2008-08 ,pp. : 1018-1028

Informa Healthcare

Access to resources Recommend Favorite

Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis

By Norum J.   Olsen J. A.   Wist E. A.   Lønning P. E.  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 153-164

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective

By Berger K.   Fischer T.   Szucs T.D.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1894-1901

Elsevier

Access to resources Recommend Favorite

The potential of proton beam radiation therapy in breast cancer

By Björk-Eriksson Thomas   Glimelius Bengt  

Acta Oncologica, Vol. 44, Iss. 8, 2005-12 ,pp. : 884-889

Informa Healthcare

Access to resources Recommend Favorite

The potential of proton beam radiation therapy in gastrointestinal cancer

By Ask Anders   Johansson Bengt   Glimelius Bengt  

Acta Oncologica, Vol. 44, Iss. 8, 2005-12 ,pp. : 896-903

Informa Healthcare

Access to resources Recommend Favorite